Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Venturing into the Brave New World of Diagnostics Start-Ups

This article was originally published in Start Up

Executive Summary

Few diagnostics start-ups are {bona fide} business successes, and that has put a damper on venture capital interest in the field. But this hasn't stopped start-ups trying to meet needs in cancer diagnostics, sample preparation and point-of-care.

You may also be interested in...



MicroSure Inc.

Ultimately, MicroSure hopes to sell cancer diagnostics to predict a tumor's aggressiveness. Meanwhile, the company will manufacture and sell products for improved biological sample handling.

CytoLogix Corp.

Diagnostics; Cytology. CytoLogix automates specialty staining for slide-based cellular analysis.

Exigent Diagnostics

Exigent's mission is to provide high-quality point of care test results at reference laboratory prices.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC089889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel